HAVCR2 and leukemia: When analyzing the target cells for the expression of the membrane-bound ligand of TIM-3, CEACAM1, we observed that many leukemia and lymphoma cell lines upregulate CEACAM1 when exposed to Th1 cytokines IFN-γ and TNF-α (Figure 1B).